文献速递甲状腺疾病

游离T3/游离T4比值预测儿童自身免疫性甲亢停用抗甲状腺药物后复发

The Free T3/Free T4 Ratio Predicts Relapse After Antithyroid Drug Withdrawal in Pediatric Autoimmune Hyperthyroidism.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

这项回顾性队列研究纳入80例自身免疫性甲亢患者,评估游离T3/游离T4比值对停用抗甲状腺药物后复发的预测价值。48例停药患者中24例(50%)复发,复发者诊断时和停药时FT3/FT4比值均显著更高。诊断时FT3/FT4比值≥0.42预测复发的敏感性83%、特异性66%,多因素分析中该比值≥0.42(OR 7.18;

要点

  • 诊断时FT3/FT4比值≥0.42预测复发敏感性83%、特异性66%。
  • 停药时FT3/FT4比值在复发者中亦显著更高(中位0.43 vs 0.33)。
  • 诊断时FT3/FT4比值≥0.42和眼眶病变是复发独立预测因素。

核心结论

  • 诊断时和停用抗甲状腺药物前测量的FT3/FT4比值是自身免疫性甲亢复发的显著预测因素。
  • 该参数可能有助于指导治疗时长和停药决策。

研究设计与样本

  • 回顾性队列研究,纳入2000至2021年诊断的80例自身免疫性甲亢患者。
  • 收集诊断时和随访期间的临床与生化数据,评估尝试停用抗甲状腺药物患者的缓解可能性。
  • 采用受试者工作特征分析和逻辑回归识别复发预测因素。

主要发现

  • 48例停用抗甲状腺药物的患者中24例(50%)复发,多发生在12个月内。
  • 诊断时FT3/FT4比值≥0.42预测复发敏感性83%、特异性66%。

关键数值与推荐

  • 诊断时FT3/FT4比值≥0.42预测复发的敏感性83%、特异性66%。

临床怎么用

  • 对儿童自身免疫性甲亢患者,可在诊断时计算FT3/FT4比值以辅助评估复发风险。
  • 停用抗甲状腺药物前可参考FT3/FT4比值,结合眼眶病变等因素共同决策治疗时长和停药时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The likelihood of remission in patients with autoimmune hyperthyroidism (AH) depends on several prognostic factors. The free T3 (FT3)/free T4 (FT4) ratio has been suggested as a potential marker of disease severity and prognosis. OBJECTIVE: To evaluate the prognostic value of the FT3/FT4 ratio in predicting the likelihood of relapse in patients with AH. METHODS: This retrospective cohort study included 80 patients with AH diagnosed between 2000 and 2021. Clinical and biochemical data were collected at diagnosis and during follow-up to assess the likelihood of remission in patients attempting to discontinue antithyroid drug (ATD) therapy. Receiver operating characteristic analysis and logistic regression were used to identify predictors of relapse. RESULTS: Of the 48 patients who discontinued ATD therapy, 24 (50%) relapsed, predominantly within 12 months. The FT3/FT4 ratio was significantly higher in patients who relapsed both at diagnosis (median 0.46 vs 0.36; P .001) and at ATD withdrawal (median 0.43 vs 0.33; P < .001). An FT3/FT4 ratio ≥0.42 at diagnosis predicted relapse with 83% sensitivity and 66% specificity. In a multivariate analysis, FT3/FT4 ratio ≥0.42 at diagnosis (odds ratio 7.18; P .012) and the presence of orbitopathy were identified as independent predictors of relapse. Longer time to FT3 normalization (P .02) and orbitopathy were associated with relapse in univariate analyses (P .039). CONCLUSION: The FT3/FT4 ratio, measured both at diagnosis and before ATD withdrawal, is a significant predictor of relapse in AH. This parameter may represent a useful tool for guiding decisions about treatment duration and withdrawal.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Abbate M, Vincenzi G, Mora S, et al. The Free T3/Free T4 Ratio Predicts Relapse After Antithyroid Drug Withdrawal in Pediatric Autoimmune Hyperthyroidism. J Clin Endocrinol Metab. 2026. PMID: 41913979. doi:10.1210/clinem/dgag130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。